bis

DTC wellness tests are promoted directly to consumers via commercials, televisions, and internet, thereby resulting in increased awareness related to DTC products. Consumers can get the information about the test that they have ordered through the company’s online portal without visiting any physician or through the insurance companies. Major companies such as LabCorp, Quest Diagnostics, and Everlywell, Inc. have dedicated their efforts to developing reliable consumer-facing wellness testing services. The U.S. DTC wellness testing market is projected to reach $4,946.3 million by 2032 from $878.9 million in 2022, at a CAGR of 18.86% during the forecast period 2022-2032. The growth in the U.S. DTC wellness testing is expected to be driven by the shift of the healthcare industry in the U.S. from being physician-focused to being consumer-focused. In addition, the rise in awareness related to DTC wellness testing among consumers and growing consumer convenience are driving ... Continue reading →

Prostate cancer testing is essential in precision medicine because it assures the safe and successful use of tailored therapies. The majority of the companies in the global prostate cancer testing market provide biomarker tests that are urine, blood, and tissue-based, as well as testing services. Furthermore, applications of prostate cancer testing are primarily clinical and research. In 2021, the global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032. The growth in the global prostate cancer testing market is expected to be driven by high investments in the field of cancer research and the rising prevalence of prostate cancer globally. In addition, the focus of business leaders is establishing a deep understanding to address the unmet needs in clinical research to understand the prostate cancer market. Impact of COVID-19 During the ... Continue reading →

The Canada laparoscopy devices market is expected to be driven by growing technological innovations in the field of laparoscopy, the growing burden of chronic diseases, and the rising preference for minimally invasive procedures. The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022–2031. The market is driven by factors such as the rising preference for minimally invasive surgeries, growing geriatric population, rising bariatric population, and rising approval for robotic surgical systems. Canada Laparoscopy Devices Market Segmentation Impact of COVID-19 The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the Canada laparoscopy devices market. COVID-19 led to a decline in the Canada laparoscopy devices market, as elective and surgical procedures were stopped during the lockdown. Overall, the supply ... Continue reading →

According to BIS Research, the global wearable patches market consists of wearable patches that are used for diagnostic, monitoring, and therapeutic purposes. These patches are used for various purposes, such as heart rate monitoring, blood glucose monitoring, and SpO2 levels, among others. The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031. Furthermore, the market is anticipated to grow at a CAGR of 11.06% during the forecast period 2022-2031. The market is driven by factors such as the continuous monitoring and minimum interference with body movement for measurement of vital signs of patients, increasing prevalence of chronic disorders (diabetes, strokes, etc.), rising technological advancement (increased connectivity with cell phones and precise data), and growing geriatric population. Recent Developments in the Global Wearable Patches Market •    In September 2022, ... Continue reading →

With the increasing burden of cancer, the demand for flow cytometry has increased worldwide. Flow cytometry provides quick and effective data collection from a heterogenous mixture of fluids. This is primarily due to the extensive adoption of flow cytometry-based products for improving the diagnosis and screening of cancer, particularly hematological malignancies. Additionally, manufacturers are significantly investing in research and development (R&D) to expand their respective product portfolios by developing multiparametric and next-generation flow cytometry solutions for cancer diagnostic testing The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032. The market is driven by factors such as the increasing burden of cancer, expansion of applications in flow cytometry for research activities, innovation in ... Continue reading →

There has been a significant increase in the need for laboratory informatics adoption at all levels. This expanded usage of laboratory informatics has enabled end customers to describe particular system requirements, prompting suppliers to design more appealing and practical products and feasible laboratory informatics choices. Global Laboratory Informatics Market Industry Overview The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032. The growth in the global laboratory informatics market is expected to be driven by the increased efficiency of laboratories due to their usage and better data management. Additionally, it saves time and money. Impact of COVID-19 During the COVID-19 pandemic, the development of laboratory software and technologies really took off as people were working remotely, and thus digital solutions became a ... Continue reading →

The treatment of extensive stage small cell lung cancer has been extremely challenging owing to poor survival rate of the patients. The median overall survival reported among the extensive stage small cell lung cancer patients has been slightly above a year while the overall progression free survival is reported to be of six months. Before the emergence of immune checkpoint inhibitors, traditional chemotherapy  which included etoposide in combination with platinum (cisplatin or carboplatin) were the treatment mainstay however since the approval of immune checkpoint inhibitors; these have been included in the standard treatment regimen along with chemotherapy. Competitive Landscape The current global extensive stage small cell lung cancer market has two approved immune checkpoint inhibitors namely Imfinzi (Durvalumab) from AstraZeneca PLC and Tecentriq (Atezolizumab) from F. Hoffmann La-Roche Ltd. Zepzelca (Lurbinectedine) from Jazz Pharmaceuticals Plc and Cosela ... Continue reading →

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others.  The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially because of the reduced access to care for other illnesses. As the number of individuals becoming ill from COVID-19 kept increasing and for the protection of healthy individuals from being affected by the disease, ... Continue reading →

With the growing worldwide awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing medical radiation, medical imaging companies are focused on employing dose-lowering technologies in imaging equipment. The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation. Impact of COVID-19 The decline in imaging volumes during the COVID-19 pandemic impacted the utilization of radiation diagnostic equipment. All radiology equipment had to be thoroughly ... Continue reading →

The integration of OR software solutions in emerging countries, technological advancements in CT imaging, and the adoption of intraoperative imaging systems are some of the major opportunities in the global ambulatory surgical center operating room integration systems market.  The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032. The growth in the global ambulatory surgical center operating room integration systems market is expected to be driven by the growing demand for outpatient care, the cost savings in ASCs, and the growing government support and funding for ASCs.   Market Segmentation: Segmentation 1: by Component •    OR Visualization •    OR Lighting •    OR Imaging •    OR Integration Software •   ... Continue reading →

In the future, chatbots can be seen enabling a smooth patient experience by helping patients in scheduling appointments, issuing reminders for the same, improving medication adherence, and acting as therapists. According to the new market intelligence report by BIS Research, "Global Chatbots in Healthcare Market – Analysis and Forecast, 2019-2029", the global chatbots in healthcare generated $36.5 million revenue in 2018 and is estimated to grow over $498.1 million by the end of 2029. The market is projected to grow at a CAGR of 26.29%, during the forecast period from 2019 to 2029.  Factors driving the growth of the market are the rising market penetration of smart devices and improved internet connectivity, need for cost optimization and customer experience enhancement, and advancements in NLP and speech recognition.  BIS Research Report: https://bisresearch.com/industry-report/chatbots-healthcare-market.html According ... Continue reading →

The NGS kits market is a disruptive technical advancement in the life sciences sector that has cleared the way for the creation of various ground-breaking medicinal techniques intended to solve the main global health concern. NGS Kits Market Industry Overview In 2021, the global NGS kits market was valued at $4,553.6 million, and it is expected to reach $26,057.4 million by 2032, growing at a CAGR of 17.27% during the forecast period 2022-2032. The growth in the global NGS Kits market is expected to be driven by advancements in sequencing technology benefiting the treatment and diagnostics coupled with the presence of regulatory framework pertaining to sequencing and governments investing in large clinical and diagnostic laboratories to enable reliable NGS testing for a variety of chronic and infectious ailments. Impact •   The presence of NGS kits providers of NGS kits in regions such as North America and Europe has a major impact on the market. For instance, ... Continue reading →

Global molecular oncology diagnostics market is a well-established market and is expected to grow further in the coming years due to the continuous increase in the demand for innovative products in molecular oncology diagnostics. The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032. The growth in the global molecular oncology diagnostics market is expected to be driven by the rising prevalence of cancers and increased transformations in biomarker identification.     Impact •   The presence of major kit and assay providers of molecular oncology diagnostics has a major impact on the market. For instance, in March 2021, Biocartis NV launched Idylla GeneFusion Assay as a Rapid Lab Workflow Solution for gene fusion testing. This product provides a much faster testing solution for laboratories in comparison ... Continue reading →

The laparoscopy devices market is still in the development phase. Increased research and development activities are underway to develop more products. The market is driven by factors such as the rising preference for minimally invasive surgeries and increase in the prevalence of chronic diseases in the geriatric population, among others. The rising preference for surgeries over open surgeries is leading to the increased demand for laparoscopy devices such as laparoscopes and energy devices, and the integration of industry with robotics is a major opportunity in the Middle East and North Africa laparoscopy devices market.   The Middle East and North Africa laparoscopy devices market was valued at $752.0 million in 2021 and is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031. The market is driven by factors such as the rising preference for minimally invasive surgeries, increase in the prevalence of chronic ... Continue reading →

The development in providing efficient health-care services is heavily dependent on advances in the information technology, and particularly in the ability to record and store information easily and economically and share it securely among disparate applications and systems.  However, less than 10% of healthcare organizations regularly share medical information with providers outside of their organization. The lack of interoperability and limited linkage between the healthcare storage systems, makes it difficult to transmit, retrieve, clean and analyze data. Thus, most of the data is contained in silos. Additionally, there are widespread concerns regarding security and privacy  about storage and exchange of data as healthcare organizations have been subjected to growing number of data breaches and malicious attacks. Blockchain technology is increasingly being touted as the panacea for the interoperability and security issues that plague the antiquated health systems. The ... Continue reading →

 Surgical microscopes have been used in a variety of surgeries, including neuro and spine surgery, ENT surgery, dentistry, ophthalmology, and plastic and reconstructive surgery, due to numerous advantages such as clear and bright visualization, easy documentation and adaptation, stability, maneuverability, and improved ergonomics. The surgical microscopes market report highlights that the overall surgical microscopes market was valued at $928.3 million in 2020 and is expected to reach $3,578.2 million by the end of 2031. The market is expected to grow at a CAGR of 13.3% during the forecast period from 2021 to 2031. Market Segmentation Surgical Microscopes Market (by Product Type) Different technologies that have been studied and analyzed under the surgical microscopes market report include conventional microscopes and advanced microscopes. Conventional microscopes generate the highest revenue in the surgical microscopes market, and advanced microscopes are expected to ... Continue reading →

The digital PCR technology has emerged to be an integrative aspect of healthcare practices by providing most diagnostic laboratory tests equipped with infectious disease, oncology, and genetics. The massively parallel methods transcending digital PCR-based molecular diagnostics further enable absolute quantification through partitioning the reaction. In addition, the advantages of digital PCR over conventional PCR such as Real-Time PCR (RT-PCR) and its rising adoption is anticipated to grow further in the coming years. The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development.   ... Continue reading →

Proteins are found in complex biological materials, hence protein complex analysis entails a thorough investigation of their structure and function. Modern protein complex analysis techniques can be used to determine the structure of protein complexes. Currently, there is a lot of work being done to describe and comprehend molecular structures and molecular recognition mechanisms using cryo-electron microscopy (EM), small angle X-ray scattering (SAXS), nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography. Equipment for 3D protein structure analysis is available from reputable manufacturers including Bruker Corporation, JEOL Ltd., and Spectris plc depending on what is required. These tools can meet the laboratory's throughput requirements. In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032. The ... Continue reading →

The rapidly evolving and dynamic nature of the worldwide phosphoramidite market presents a variety of possibilities for businesses involved in the life sciences. Additionally, businesses that are already engaged in the phosphoramidite development stage are working to introduce a variety of manufacturing choices to the market in an attempt to improve the standard of oligonucleotides. Nowadays, businesses involved in the global phosphoramidite market are putting more of an emphasis on premium and customised products. Major companies including Merck KGaA, Maravai LifeSciences Holdings, Inc., LGC Science Group Holdings Limited, and Thermo Fisher Scientific Inc. are also making significant investments in research and development for the phosphoramidite goods they are developing. The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032. The market growth can be ascribed to ... Continue reading →

The global serum-free media market is progressing rapidly with a significant increase in research and development activities pertaining to a wide range of animal component-free products for disease detection, accentuating their criticality in healthcare. Serum-free media has a critical role in the cellular diagnostics approach, as it ensures the safe and effective application for improved cell culture and cell therapy-based methods. The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development. Impact Several techniques are employed in the development of serum-free media utilization for the ... Continue reading →